Clincosm LogoSign in Get a demo

stage iv fallopian tube cancer

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,

Recruiting
  • Ovarian Cancer
  • +13 more
  • Mind-body resilience training
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jun 28, 2022

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,

Terminated
Has Results
  • Stage III Fallopian Tube Cancer
  • +14 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 17, 2021

Metastatic Ovarian Carcinoma, Peritoneal Carcinomatosis, Stage III Ovarian Cancer Trial in Pierre-Bénite (Combined PIPAC / IV

Recruiting
  • Metastatic Ovarian Carcinoma
  • +6 more
  • Combined PIPAC / IV chemotherapy treatment
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Aug 4, 2021

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
Has Results
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +23 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 25, 2020

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Bevacizumab
  • +5 more
  • Anniston, Alabama
  • +631 more
Jul 19, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer Trial (drug, procedure, other)

Withdrawn
  • Stage IIIA Fallopian Tube Cancer
  • +11 more
  • (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG)
  • +2 more
  • (no location specified)
Jun 4, 2018

Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,

Terminated
Has Results
  • Nausea and Vomiting
  • +26 more
  • Adjuvant Therapy
  • +7 more
  • Hinsdale, Illinois
  • +1 more
Apr 24, 2018

YKL-40 in Serum Samples From Newly Diagnosed Stage III-IV

Terminated
  • Fallopian Tube Adenocarcinoma
  • +29 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Mobile, Alabama
  • +130 more
May 21, 2018

Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer Trial in United States (Laboratory

Completed
Has Results
  • Stage IA Fallopian Tube Cancer
  • +23 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Mobile, Alabama
  • +45 more
Sep 12, 2017

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Canada, United

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +5 more
  • Gamma-Secretase Inhibitor RO4929097
  • Laboratory Biomarker Analysis
  • Beverly Hills, California
  • +11 more
Apr 17, 2017

Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome Trial in United States (Carboplatin, Glutathione, Laboratory

Completed
Has Results
  • Chemotherapeutic Agent Toxicity
  • +15 more
  • Mobile, Alabama
  • +389 more
Jan 5, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Malignant Ovarian Clear Cell Tumor, Malignant Ovarian Serous Tumor, Recurrent Fallopian Tube Carcinoma Trial (Aldesleukin,

Withdrawn
  • Malignant Ovarian Clear Cell Tumor
  • +16 more
  • Aldesleukin
  • +3 more
  • (no location specified)
Feb 15, 2016

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial

Withdrawn
  • Recurrent Fallopian Tube Cancer
  • +32 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • (no location specified)
Dec 17, 2013